Literature DB >> 29943165

Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients: reply.

Avsar Zerman1, Muge Aydogdu2, Gul Gursel1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29943165     DOI： 10.1007/s11739-018-1902-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?

Authors:  Maria Paola Arellano-Maric; Cesare Gregoretti; Marieke Duiverman; Wolfram Windisch
Journal:  Eur Respir J       Date:  2017-06-22       Impact factor: 16.671

2.  BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.

Authors:  A Craig Davidson; Stephen Banham; Mark Elliott; Daniel Kennedy; Colin Gelder; Alastair Glossop; Alistair Colin Church; Ben Creagh-Brown; James William Dodd; Tim Felton; Bernard Foëx; Leigh Mansfield; Lynn McDonnell; Robert Parker; Caroline Marie Patterson; Milind Sovani; Lynn Thomas
Journal:  Thorax       Date:  2016-04       Impact factor: 9.139

3.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients.

Authors:  Gul Gursel; Avsar Zerman; Burcu Basarik; Kamil Gonderen; Muge Aydogdu; Serriyye Memmedova
Journal:  Intern Emerg Med       Date:  2018-03-06       Impact factor: 3.397

Review 4.  Initiation of Noninvasive Ventilation for Sleep Related Hypoventilation Disorders: Advanced Modes and Devices.

Authors:  Bernardo J Selim; Lisa Wolfe; John M Coleman; Naresh A Dewan
Journal:  Chest       Date:  2017-07-08       Impact factor: 9.410

5.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients: comment.

Authors:  Fatma Yıldırım; Edoardo Piervincenzi; Güniz Meyancı Köksal; Antonio Esquinas
Journal:  Intern Emerg Med       Date:  2018-06-06       Impact factor: 3.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.